Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen and Graft Atherosclerosis Research Trial
NCT00000605Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 1996
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of conjugated estrogens, medroxyprogesterone acetate in coronary arteriosclerosis, Graft occlusion, sponsored by National Heart, Lung, and Blood Institute. Started Aug 1996; status: completed.
02
Drugs
conjugated estrogensmedroxyprogesterone acetate
03
Conditions
coronary arteriosclerosisGraft occlusion
Beyond the preview
Go deeper on NCT00000605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000605.